Phosphodiesterase‐5 inhibitors for left ventricular assist device implantation complicated by right ventricular failure

enthalten in: ESC Heart Failure | 2023

von Papathanasiou, M. | Jakstaite, A. | Mincu, R. | +4

Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis

enthalten in: ESC Heart Failure | 2022

von Papathanasiou, M. | Jakstaite, A. | Oubari, S. | +10

Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapy

enthalten in: ESC Heart Failure | 2022

von Pohl, J. | Totzeck, M. | Mincu, R. | +7

Ventricular assist device for a coronavirus disease 2019‐affected heart

enthalten in: ESC Heart Failure | 2021

von Rassaf, T. | Totzeck, M. | Mahabadi, A. | +16

Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer—a meta‐analysis

enthalten in: ESC Heart Failure | 2020

von Michel, L. | Mincu, R. | Mrotzek, S. | +4

Impact of diabetes on clinical outcome of patients with heart failure undergoing ICD and CRT procedures : results from the German Device Registry

enthalten in: ESC Heart Failure | 2020

von Kaya, E. | Senges, J. | Hochadel, M. | +10

Prolonged mechanical ventilation after left ventricular assist device implantation : risk factors and clinical implications

enthalten in: ESC Heart Failure | 2019

von Papathanasiou, M. | Mincu, R. | Lortz, J. | +6

Heart failure from cancer therapy : can we prevent it?

enthalten in: ESC Heart Failure | 2019

von Totzeck, M. | Mincu, R. | Heusch, G. | +1